Dallas, Texas 08/19/2013 (Financialstrend) – Last week, Merck & Co., Inc. (NYSE:MRK) made an announcement regarding the sales of Zilmax. It is said by the company that it is suspending the sales of Zilmax on a temporary basis. Zilmax is the famous animal feed additive that is used for the fattening the cattle quickly for the purpose of slaughtering. The temporary suspension was announced by Merck & Co after two of the meat companies said that this animal feed additive caused the trouble in walking for the heifers. It was said by the largest meat packer of United States, Tyson Foods, Inc. (NYSE:TSN) during last week, that the company would be stopping the usage of meat from cattle that was fed with Zilmax in the company’s products.
It was told by Merck & Co that the company is confident that Zilmax would not be responsible for the adverse symptoms that were described by Tyson Foods Inc in an e-mail to International Business Times. In addition to this, it was reported by Reuters that the second leading meat processor, JBS USA Holdings Inc has screened a video that was showing the cattle which are not able to walk properly at a cattle industry conference. However, it is still not clear whether JBS USA Holdings Inc has suspended the purchase of cattle fed with Zilmax.
Last week, US Food and Drug Administration said that it was under the process of gathering information on additive, Zilmax along with the manufacturer of the drug, Merck & Co in order to determine whether the drug is unsafe. In an e-mail response to the query from Reuters, US Food and Drug Administration said that it has received only a small number of reports of lameness in the cattle which received the feed that contained Zilmax. It was said by FDA that it would be reviewing any new information regarding the additive and would be notifying Merck & Co and the public if it was determined that the product is carrying some safety concerns.
This report is for information purposes only, and is neither a solicitation or recommendation to buy nor an offer to sell securities. Financials Trend is not-a-registered-investment-advisor. Financials Trend is not a broker-dealer. Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. Financials Trend accepts no liability for any losses arising from an investor's reliance on the use of this material. Financials Trend sometimes gets compensated up to one hundred and fifty thousand dollars per month for featuring particular stocks. See site disclaimer for complete compensation. Financials Trend and its affiliates or officers currently hold no shares of these stocks. Financials Trend and its affiliates or officers will purchase and sell shares of common stock of these stocks, in the open market at any time without notice. Financials Trend will not update its purchases and sales of these stocks in any future postings on Financials Trend's websites. Certain information included herein is forward-looking within the context of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. The words "may", "would," "will," "expect," "estimate," "anticipate," "believe," "intend," " project," and similar expressions and variations thereof are intended to identify for ward-looking statements. Such forward- looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. *Financials Trend does not set price targets on securities. Never invest into a stock discussed on this web site or in this email alert unless you can afford to lose your entire investment.